| P2093 | author name string | Cheryl Bushnell | |
| | Elizabeth Sullivan | |
| P2860 | cites work | Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies. | Q46898774 |
| | The menstrual cycle and migraine: a time-series analysis of 20 women migraineurs. | Q53757805 |
| | Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. | Q54041700 |
| | A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. | Q54130765 |
| | Naproxen sodium in short-term prophylaxis of pure menstrual migraine: pathophysiological and clinical considerations | Q61852268 |
| | The role of estradiol withdrawal in the etiology of menstrual migraine | Q70456111 |
| | The role of progesterone in menstrual migraine | Q70565949 |
| | Menstrual cycle and headache in a population sample of migraineurs | Q73230734 |
| | Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine | Q79398824 |
| | Disability associated with headaches occurring inside and outside the menstrual period in those with migraine: a general practice study | Q81660721 |
| | The International Classification of Headache Disorders: 2nd edition | Q29547231 |
| | Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies | Q31119065 |
| | Prevalence of migraine on each day of the natural menstrual cycle | Q34336315 |
| | Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. | Q34341673 |
| | Defining the relationship between ovarian hormones and migraine headache | Q34453101 |
| | The influence of estrogen on migraine: a systematic review | Q34514773 |
| | Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study | Q34597128 |
| | Age- and sex-specific incidence rates of migraine with and without visual aura | Q34623596 |
| | Medication overuse headache from antimigraine therapy: clinical features, pathogenesis and management | Q35933709 |
| | Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine | Q36332493 |
| | Hormonal management of migraine associated with menses and the menopause: a clinical review | Q36735671 |
| | New theories in the pathogenesis of menstrual migraine | Q37313507 |
| | Epidemiology and biology of menstrual migraine | Q37348696 |
| | Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials | Q39301902 |
| | Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine. | Q39320854 |
| | Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies | Q39336473 |
| | Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine | Q39389288 |
| | Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration | Q40659314 |
| | Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks | Q43265529 |
| | Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation | Q43277042 |
| | Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. | Q43551354 |
| | A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine | Q44995793 |
| | Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine | Q45179690 |
| | Frovatriptan for acute treatment of migraine associated with menstruation: results from an open-label postmarketing surveillance study. | Q45922133 |
| | Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteers | Q46051440 |
| | Naratriptan in the short-term prophylaxis of pure menstrual migraine. | Q46519066 |
| | Suppression of estrogen-withdrawal headache with extended transdermal contraception | Q46541172 |
| | An economic evaluation of triptan products for migraine | Q46800901 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | menstruation | Q12171 |
| | migraine | Q133823 |
| P304 | page(s) | 376-384 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | Current Pain and Headache Reports | Q15761579 |
| P1476 | title | Management of menstrual migraine: a review of current abortive and prophylactic therapies | |
| P478 | volume | 14 | |